Advise and invest at innovation & growth stages in companies attractive to strategic buyers:+ Strong competitive advantage resulting in potential leadership in their strategic relevant markets+ Backed by robust intangible assets, such as patents, exclusive licenses, clinical data, trademarks+ Large enough enterprise value at exit (> 25 M CHF) to enter the radar screen of strategic
Social Profiles